-
-
June seems to have been magnesium sulfate month in both the Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology journals.
-
The raloxifene use for the heart (RUTH) trial was an international randomized, placebo-controlled trial that enrolled 10,101 postmenopausal women in two groups, one at high risk for coronary heart disease, and one with established coronary heart disease.
-
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI.
-
-
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine.
-
Preclinical data recently demonstrated the extreme sensitivity of BRCA-deficient cells to inhibition of the single-strand repair enzyme poly(ADP-ribose) polymerase (PARP).
-
Although it is well known that incessant atrial tachyarrhythmias can cause left ventricular (LV) dysfunction, little is known about focal atrial tachycardia and LV dysfunction.
-
Six years ago, Wild and Law, two British physicians, proposed that a single pill with multiple active components could profoundly reduce cardiac risk (CV).